
First-in-class селективный, partial CDK2 degrader against hearing loss and cancer, protecting against cisplatin ototoxicity and kainic acid excitotoxicity
First-in-class selective, partial CDK2 degrader against hearing loss and cancer, protecting against cisplatin ototoxicity and kainic acid excitotoxicity
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.